Epimachus of Pelusium’s biography, fact, career, awards, net worth and life story

Intro Egyptian martyr
Is Martyr
From Egypt
Type Military
Gender male
Birth

Pelusium, Egypt

Saint Epimachus of Pelusium was an Egyptian martyr.

Epimachus was born in Pelusium, and worked as a weaver along with his two companions: Theodore and Callinicos. At age 27, he heard that Youlamis the governor of Egypt was torturing the Christians. He subsequently went to El-Bakroug, (near Demera) and came before the governor, confessing his Christianity. Youlamis the governor tortured him severely, then ordered him to be squeezed on the wheel. A drop of his blood splashed on the eyes of a blind maiden, and she was able to see instantaneously. The maiden and her family converted to Christianity and were martyred by Youlamis. Furious, the governor ordered Epimachus to be crucified and his head to be cut off. The executioner drew his sword but his strength failed. The same thing happened with another executioner, and so with fourteen others. When they failed to cut off his head, they tied a rope around his neck and dragged him until he died.

A deaf and mute soldier touched the body, and he instantly heard and spoke. Some of the Christians from the city of Edku took the body and several signs and wonders took place from it. His kinsfolk from Demera carried the body to Paramoni (Coptic: ⲡⲁⲣⲁⲙⲟⲛⲓ) with great honor. The governor of Paramoni shrouded the body with expensive shrouds and built a church after Saint Epimachus, where the body was placed.

The feast of Saint Epimachus of Pelusium falls on 14 Pashons in the Coptic Orthodox Church, and on 14 October in the Eastern Orthodox Church.

You May Also Like

Michael Jaharis’s net worth, biography, fact, career, awards and life story

Michael Jaharis Net Worth: Michael Jaharis is an American businessman who has a net worth of $2.2 billion. Best known as the founder of Kos Pharmaceuticals and Vatera Healthcare Partners, Michael Jaharis is also one of the co-founders of Arisaph Pharmaceuticals. Upon his graduation from Carroll University and DePaul University where he completed his PhD, Michael Jaharis started his professional career at Miles Laboratories, working from 1961 through 1972. Since 1972, he landed the position of CEO and President of Key Pharmaceuticals until its merger with Schering-Plough Corporation more than a decade later. In 1988, Jaharis decided to found Kos Pharmaceuticals, Inc, the company that introduced Niaspan, a cholesterol-fighting drug that was later sold to Abbott Labs for $4.2 billion. Furthermore, Michael Jaharis established himself as a great philanthropist who has made generous contributions to various organizations like Weill Cornell Medical College of Cornell University, the Art Institute of Chicago, the Metropolitan Museum of Art and the Metropolitan Opera, as well as the Tufts University School of Medicine and the Columbia University Medical Center.
Read More